Skip to main content
. Author manuscript; available in PMC: 2013 Mar 23.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2010 May 15;19(4):311–320. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.001

Table 3.

OR (95% CI) of stroke/TIA participants having unrecognized risk factor, treatment, and success control for each risk factor compared to stroke-free participants in several models:

Condition Unrecognized Treated Controlled
HTN 1.48 (1.20–1.83)*
1.25 (1.01 –1.55)** 		1.51 (1.28–1.79)*
1.41 (1.19–1.66)** 		0.88 (0.80 – 0.97)*
0.90 (0.82 – 0.99)**
0.93 (0.84–1.03)†
HTN Stage 2 2.03 (1.35–3.08)*
1.78 (1.17–2.71)** 		0.82 (0.70 – 0.97)*
0.84 (0.72 – 0.98)**
0.87(0.73–1.02)†
DM 1.32 (1.03–1.70)*
1.35 (1.05–1.74)** 		1.72 (1.40–2.12)*
1.73 (1.40–2.12)** 		0.95 (0.82–1.10)*
0.92 (0.79–1.06)**
0.95(0.817–1.11)†
Dyslipidemia 0.76 (0.67 – 0.87)*
0.80 (0.70–0.91)** 		1.99 (1.77–2.23)*
1.82 (1.62–2.05)** 		1.48 (1.33–1.65)*
1.35 (1.21 –1.51)**
1.37 (1.22–1.53)†
*

univariate,

**

adjusted for age,

†

adjusted for age and medication compliance measured by the Mori sky scale.